Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures

Completed · Phase 3

Conditions studied: Epilepsy

In brief

This study will evaluate the long term safety and efficacy of pregabalin (Lyrica) when administered by itself (without any other anti-epileptic medication) to epilepsy patients for the treatment of partial seizures. This is an extension study to a previous clinical trial.

Key facts

Study ID

NCT00596466

Run by

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

People needed

75

Starts

2008-04-01

Expected to finish

2011-12-01

Last updated by the study team

2021-01-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Completed the previous protocol and wish to continue to receive pregabalin.
• Diagnosis of epilepsy with partial seizures

You may not qualify if…

• Early withdrawal from the previous protocol, an episode of status epliepticus, or primary generalized epilepsy.

Where it is running

• Pfizer Investigational Site — Phoenix, Arizona, United States
• Pfizer Investigational Site — Fayetteville, Arkansas, United States
• Pfizer Investigational Site — Fullerton, California, United States
• Pfizer Investigational Site — Long Beach, California, United States
• Pfizer Investigational Site — Modesto, California, United States
• Pfizer Investigational Site — Murrieta, California, United States
• Pfizer Investigational Site — Newport Beach, California, United States
• Pfizer Investigational Site — Temecula, California, United States
• Pfizer Investigational Site — Denver, Colorado, United States
• Pfizer Investigational Site — Jacksonville, Florida, United States
• Pfizer Investigational Site — Suwanee, Georgia, United States
• Pfizer Investigational Site — Danville, Indiana, United States
• Pfizer Investigational Site — Fort Wayne, Indiana, United States
• Pfizer Investigational Site — Kansas City, Kansas, United States
• Pfizer Investigational Site — Bowling Green, Kentucky, United States
• Pfizer Investigational Site — Lexington, Kentucky, United States
• Pfizer Investigational Site — Houma, Louisiana, United States
• Pfizer Investigational Site — Shreveport, Louisiana, United States
• Pfizer Investigational Site — Pikesville, Maryland, United States
• Pfizer Investigational Site — Worcester, Massachusetts, United States
• Pfizer Investigational Site — Detroit, Michigan, United States
• Pfizer Investigational Site — Flowood, Mississippi, United States
• Pfizer Investigational Site — Great Falls, Montana, United States
• Pfizer Investigational Site — Charlotte, North Carolina, United States
• Pfizer Investigational Site — Charlotte, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.